Insider Transactions in Q1 2024 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2024
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,971
-1.78%
|
$125,391
$21.1 P/Share
|
|
Mar 15
2024
|
Marc Stapley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,780
+3.39%
|
-
|
|
Mar 15
2024
|
Rebecca Chambers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,189
-1.47%
|
$45,969
$21.1 P/Share
|
|
Mar 15
2024
|
Rebecca Chambers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,318
+2.82%
|
-
|
|
Mar 06
2024
|
Phillip G. Febbo Chief Scientific & Med Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,904
+30.01%
|
-
|
|
Mar 06
2024
|
Rebecca Chambers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,856
+29.28%
|
-
|
|
Mar 06
2024
|
Jonathan Wygant VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,942
+32.8%
|
-
|
|
Mar 06
2024
|
Annie Mc Guire SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
49,880
+33.88%
|
-
|
|
Mar 06
2024
|
John Leite Chief Commercial Officer-CLIA |
BUY
Grant, award, or other acquisition
|
Direct |
49,880
+36.83%
|
-
|
|
Mar 06
2024
|
Marc Stapley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
114,724
+26.15%
|
-
|
|
Mar 02
2024
|
Annie Mc Guire SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,347
-8.39%
|
$104,328
$24.0 P/Share
|
|
Mar 02
2024
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,286
-5.97%
|
$318,864
$24.0 P/Share
|
|
Mar 02
2024
|
John Leite Chief Commercial Officer-CLIA |
SELL
Payment of exercise price or tax liability
|
Direct |
3,008
-7.78%
|
$72,192
$24.0 P/Share
|
|
Mar 02
2024
|
Rebecca Chambers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,112
-6.73%
|
$146,688
$24.0 P/Share
|
|
Mar 02
2024
|
Jonathan Wygant VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,337
-8.51%
|
$56,088
$24.0 P/Share
|
|
Mar 01
2024
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Direct |
10,000
-21.01%
|
$240,000
$24.36 P/Share
|
|
Mar 01
2024
|
Evan/ Fa Jones Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.36%
|
$130,000
$13.19 P/Share
|